Preview of the Black Swan Research Initiative’s First US Cure Trial

This week, Dr. Shaji Kumar shares the details of the upcoming US ASCENT “Cure Trial” in a video interview on IMF-TV. ASCENT stands for Aggressive Smoldering Cure Evaluating Novel Rx Transplant. This long-anticipated clinical trial, expected to launch in late Fall 2016, is based on key tenets of the IMF’s Black Swan Research Initiative® (BSRI)®:

iStopMM (Iceland Screens Treats or Prevents Multiple Myeloma) really will stop myeloma for a whole country—Iceland!

As announced this week, the IMF is funding the iStopMM (Iceland Screens Treats or Prevents Multiple Myeloma) study, an exciting new addition to the portfolio of more than 35 Black Swan Research Initiative® (BSRI®) projects. Dr. Sigurdur Kristinsson (University of Iceland) is the lead investigator.

To collaborate, or not to collaborate, that is the question

The successes achieved by the IMF’s International Myeloma Working Group (IMWG) are due, in large part, to collaboration. Bringing myeloma researchers together to produce consensus guidelines and to brainstorm about new research ideas, such as the Black Swan Research Initiative® – the IMF’s “Myeloma Moonshot” – has produced significant breakthroughs, advanced understanding and improved patient outcomes.

The Black Swan Research Initiative® Is the “Myeloma Moonshot”

Vice President Joe Biden’s cancer “moonshot” has been very much in the news since it was made widely public in President Barack Obama’s State of the Union speech earlier this month. Most commentary has been positive – who does not want more money to go for cancer research? Apparently, the National Cancer Institute’s budget will be increased by $260.5 million to a total of $5.21 billion in the recently approved fiscal 2016 budget.

Myeloma Forecast for 2016: What’s exciting, what’s real…and who do you trust?

As we start off 2016, there is excitement in the air. Three new drug approvals, the Black Swan Research Initiative® is moving strongly into cure trials; it seems that we have myeloma on the run! Yet the reality is that we all know friends, support group members, patients who are not doing well, whose lives are threatened by myeloma despite all that is new and wonderful.

Pages